Cita APA

Zang, H., Qian, G., Arbiser, J., Owonikoko, T. K., Ramalingam, S. S., Fan, S., & Sun, S. (2020). Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol. Mol Oncol.

Chicago Style Citation

Zang, Hongjing, Guoqing Qian, Jack Arbiser, Taofeek K. Owonikoko, Suresh S. Ramalingam, Songqing Fan, i Shi‐Yong Sun. "Overcoming Acquired Resistance of EGFR‐mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib, With the Natural Product Honokiol." Mol Oncol 2020.

Cita MLA

Zang, Hongjing, et al. "Overcoming Acquired Resistance of EGFR‐mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib, With the Natural Product Honokiol." Mol Oncol 2020.